Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-11-08
2008-08-26
Fetterolf, Brandon (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120
Reexamination Certificate
active
07416851
ABSTRACT:
The present invention provides methods of diagnosis and prognosis of human chronic lymphocytic leukemia (CLL) in a subject a patient in need thereof. The methods of the present invention involve measuring the expression profile of two known genes: LPL and ADAM29; and comparing the ratio of their expression to diagnose the presence of CLL or to prognose the likelihood of developing CLL or the symptoms consistent with CLL.
REFERENCES:
patent: 2006/0099603 (2006-05-01), Davi et al.
Guo et al., J Pharmacology and Experimemtal Therapeutics, 2002, 300(1): 206-212.
Vallejo Biochimie, 2000, 82:1129-1133.
Tockman et al, Cancer Research, 1992, 52:2711s-2718s.
Carrere, Gut, 1999, 44:545-551.
Alberts et al., Molecular Biology of the cell, 3rd Ed 1994, p. 465.
Lewin, Genes VI, Oxford University Press, NY, Chapter 29, 1997, p. 847-848.
Fu et al, EMBO Journal, 1996, 15:4392-4401.
Mallampalli et al., Biochem J, 1996, 318:333-341.
Shantz and Pegg, 1999, Int J Biochem Cell Biol., 31:107-122.
McClean and Hill, Eur J Cancer, 1993, 29:2243-2248.
Greenbaum et al, Genome Biol, 2003, 4(9): 117.1-117.8.
Brennan et al, J Autoimmunity, 1989, 2:177-186.
Eriksson et al, Diabetologia, 1992, 35:143-147.
Hell et al, Laboratory Investigation, 1995, 73:492-496.
Powel, Pharmacogenesis, 1998, 8:411-421.
Klein et al. (J. Exp. Med. 2001; 194: 1625-1638).
(Cerretti et al., Biochemical and Biophysical Reasearch Communications 1999; 263, 810-815).
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Slamon et al. (Science vol. 235, Jan. 1987, pp. 177-182).
National Cancer Institute,“Understanding Prognosis and Cancer Statistics”, Dec. 2003.
Montesserrat (Hematology 2006; 279-284).
Guillaume Dighiero, “Unsolved issues in CLL biology and management”, Leukemia, vol. 17, 2003, pp. 2385-2391.
Douglas Pat Cerretti, et al., “Isolation of Two Novel Metalloproteinase-Disintegrin (ADAM) cDNAs That Show Testis-Specific Gene Expression”, Biochemical and Biophysical Research Communications, vol. 263, No. 3, 1999, pp. 810-815.
Rener Xu, et al., “Molecular Cloning and Mapping of a Novel ADAM Gene (ADAM29) to Human Chromosome 4”, Genomics, vol. 62, 1999, pp. 537-539.
Atsuko Takagi, et al., “DNA sequence of lipoprotein lipase cDNA cloned from human monocytic leukemia THP-1 cells”, Nucleic Acids Research, vol. 18, No. 21, 1990, 1 page.
Yuri Vasconcelos, et al., “Combination of LPL/ADAM29 Ratio and Zap-70 Expression Can Dispense IgVH Sequencing in CLL”, American Society of Hematology, 45thAnnual meeting and exposition, Dec. 6-9, 2003, 1 page.
Pablo Oppezzo, et al., “The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia”, Blood First Edition Paper, prepublished online Mar. 31, 2005, pp. 1-31.
E. Beillard, et al., “Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)—a Europe against cancer program”, Leukemia, vol. 17, 2003, pp. 2474-2486.
U.S. Appl. No. 11/718,837, filed May 8, 2007, Davi et al.
Davi Frederic
Dighiero Guillaume
Dumas Gerard
Oppezzo Pablo
Settegrana Catherine
Fetterolf Brandon
Institut Pasteur
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Method of diagnosis/prognosis of human chronic lymphocytic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosis/prognosis of human chronic lymphocytic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosis/prognosis of human chronic lymphocytic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4019338